Home Research-feed Channel Rankings GCT THU AI TR Open Data Must Reading

views: 18

Jonathan E. Rosenberg

Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA

Sign in to view more

Show Academic Trajectory

Ego Network

D-Core

Research Interests

Author Statistics

Experience

Education

Bio

None

Papers348 papers

Sort

By YearBy Citation

Antibody-Drug Conjugates in Urothelial Carcinomas

Michal Sarfaty,Jonathan E. Rosenberg

Current Oncology Reports, no. 2 (2020): 1-8

Bibtex

Utility of Routine Preoperative 18 F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography ( 18 F-FDG PET/CT) in Identifying Pathologic Lymph Node Metastases at Radical Cystectomy

Shawn Dason,Nathan C Wong,Timothy F Donahue, Andreas Meier,Junting Zheng,Lorenzo Mannelli, Pier Luigi Di Paolo, Lucas W Dean,Victor A McPherson,Jonathan E Rosenberg,Dean F Bajorin, Marinella Capeanu

The Journal of urology, (2020)

WOSBibtex

746P EV-201: Long-term results of enfortumab vedotin monotherapy for locally advanced or metastatic urothelial cancer previously treated with platinum and PD-1/PD-L1 inhibitors

P. O'Donnell,M.D. Galsky,J.E. Rosenberg,D.P. Petrylak,A.V. Balar,B.A. McGregor,E. Heath,E.Y. Yu,D.I. Quinn,N.M. Hahn,M. Campbell, S-Y. Liang

Annals of Oncology, (2020)

Bibtex

Abstract B26: EV-301: A phase 3 study evaluating enfortumab vedotin versus chemotherapy in patients with locally advanced or metastatic urothelial cancer (la/mUC) who have progressed on platinum-containing chemotherapy or anti-PD-(L)1 therapy

Daniel Petrylak,Jonathan Rosenberg,Ignacio Duran,Yohann Loriot,Guru Sonpavde, Chunzhang Wu, Elaina Gartner,Amal Melhem Bertrandt,Thomas Powles

Clinical Cancer Research, (2020)

Bibtex

Abstract A14: Next-generation sequencing of Bacille Calmette-Guerin (BCG)-unresponsive tumors identifies actionable alterations for potential targeted therapy in non-muscle invasive bladder cancer

Aleksandra Walasek,Nima Almassi,Victor McPherson,Shawn Dason, Nicole Benfante, Tanya Klein,Michael F. Berger,Nikolaus Schultz,Guido Dalbagni,Dean F. Bajorin,Jonathan E. Rosenberg,Hikmat Al-Ahmadie

Clinical Cancer Research, (2020)

Bibtex

Abstract B20: Characterization of tumor mutational landscape in smokers and nonsmokers with urothelial carcinoma

Aleksandra Walasek,Nima Almassi,Min Yuen Teo,Samuel Funt,Nikolaus Schultz,Guido Dalbagni, Wenhu Hu,Hikmat Al-Ahmadie,Dean F Bajorin,Jonathan E Rosenberg,Gopakumar Iyer,Bernard H. Bochner

Clinical Cancer Research, (2020)

Bibtex

A phase II trial of durvalumab and tremelimumab in metastatic, non-urothelial carcinoma of the urinary tract

Michal Sarfaty, Karissa Whiting,Min Yuen Teo,Chung-Han Lee, Vanessa Peters, Jennifer Durocher,Ashley M Regazzi, Asia S McCoy, Grace Hettich,Achim A Jungbluth,Hikmat Al-Ahmadie,Irina Ostrovnaya

Cancer medicine, (2020)

WOSBibtex

PD18-10 IDENTIFYING THE FREQUENCY OF ACTIONABLE GENOMIC ALTERATIONS IN LOCALIZED AND METASTATIC UPPER TRACT UROTHELIAL CARCINOMA

Andrew Tracey,Nathan Wong, Timothy Clinton,Jonathan Rosenberg,Gopa Iyer,David Solit,Jonathan Coleman

The Journal of Urology, (2020)

Bibtex

Study EV-103: Durability results of enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carcinoma

Jonathan E. Rosenberg,Thomas W. Flaig,Terence W. Friedlander,Matthew I. Milowsky,Sandy Srinivas,Daniel Peter Petrylak,Jaime R. Merchan,Mehmet Asim Bilen, Anne-Sophie Carret, Nancy Yuan, Carolyn Sasse,Christopher J. Hoimes

Journal of Clinical Oncology, (2020): 5044-5044

Bibtex

IMvigor010: Primary analysis from a phase III randomized study of adjuvant atezolizumab (atezo) versus observation (obs) in high-risk muscle-invasive urothelial carcinoma (MIUC)

Maha H. A. Hussain,Thomas Powles,Peter Albers,Daniel Castellano,Siamak Daneshmand,Juergen Gschwend,Hiroyuki Nishiyama,Stephane Oudard,Darren Tayama,Nicole N. Davarpanah, Viraj Degaonkar, Yi Shi

Journal of Clinical Oncology, (2020): 5000-5000

Bibtex

Infigratinib and treatment response in advanced/unresectable or metastatic urothelial carcinoma in first-line and later-line treatment settings

Yung Lyou,Petros Grivas,Jonathan E. Rosenberg,Jean H. Hoffman-Censits,David I. Quinn,Daniel Peter Petrylak,Matt D. Galsky,Ulka N. Vaishampayan,Ugo De Giorgi, Sumati Gupta,Howard A. Burris, Jessica Rearden

Journal of Clinical Oncology, (2020): 5038-5038

Bibtex

Hcrn GU15-215: A phase II trial of atezolizumab (atezo) and bevacizumab (bev) in cisplatin-ineligible patients (pts) with advanced/unresectable urothelial cancer (UC)

Arjun Vasant Balar,Samuel Aaron Funt,Shilpa Gupta,Arkadiusz Z. Dudek, Alejandro Recio Boiles,Daniel A. Vaena,Deepak Kilari,Jonathan E. Rosenberg

Journal of Clinical Oncology, (2020)

Bibtex

Study EV-103: New randomized cohort testing enfortumab vedotin as monotherapy or in combination with pembrolizumab in locally advanced or metastatic urothelial cancer

Nataliya Mar,Terence W. Friedlander,Christopher J. Hoimes,Thomas W. Flaig,Mehmet Asim Bilen, Arjun Vasant Balar, Elizabeth Henry,Sandy Srinivas,Jonathan E. Rosenberg,Daniel Peter Petrylak, Earle Frederick Burgess,Jaime R. Merchan

Journal of Clinical Oncology, (2020)

Bibtex

PD42-06 DEFINING THE GENETIC EVOLUTION OF EPIGENETIC ALTERATIONS IN BLADDER CANCER

Timothy Clinton, Hannah Wise,Nima Almassi, Shweta Chavan,Wenhuo Hu,Shawn Dason,Eugene Pietzak,Eugene Cha,Guido Dalbagni,Gopa Iyer,Bernard Bochner,Jonathan Rosenberg

The Journal of Urology, (2020)

Bibtex

MP55-16 SKELETAL-RELATED EVENTS IN PATIENTS WITH BONE-METASTATIC CARCINOMA OF THE BLADDER OR UPPER URINARY TRACT

Nima Almassi, Imaani Easthausen, Soleen Ghafoor,Paul Christos,Timothy Donahue,Jonathan Rosenberg, Azeez Farooki

The Journal of Urology, (2020)

Bibtex

PD18-01 RADIOGRAPHIC PREDICTORS OF PATHOLOGIC RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH HIGH-GRADE UPPER TRACT UROTHELIAL CARCINOMA: RESULTS OF A PHASE 2 CLINICAL TRIAL

Nathan C. Wong,Daniel Sjoberg, Soleen Ghafoor,H. Alberto Vargas, Nicholas Silva,Bernard H. Bochner,Guido Dalbagni,S. Machele Donat,Harry W. Herr,Eugene Cha,Timothy Donahue,Eugene Pietzak

The Journal of Urology, (2020)

Bibtex

Development of Genome-Derived Tumor Type Prediction to Inform Clinical Cancer Care

Alexander Penson,Niedzica Camacho, Youyun Zheng,Anna M Varghese,Hikmat Al-Ahmadie, Pedram Razavi,Sarat Chandarlapaty, Christina E Vallejo,Efsevia Vakiani,Teresa Gilewski,Jonathan E Rosenberg, Maha Shady

JAMA ONCOLOGY, no. 1 (2020): 84.0-91

WOSBibtex

Targeting Germline and Tumor Associated Nucleotide Excision Repair Defects in Cancer

Sabine Topka, Zoe Steinsnyder, Vignesh Ravichandran, Kaitlyn Tkachuk, Yelena Kemel, Chaitanya Bandlamudi, Mogens Winkel Madsen,Helena Furberg,Ouathek Ouerfelli,Charles M Rudin,Gopa Iyer,Steven M Lipkin

Clinical cancer research : an official journal of the American Association for Cancer Research, (2020)

WOSBibtex

Partial Response and Stable Disease Correlate with Positive Outcomes in Atezolizumab-treated Patients with Advanced Urinary Tract Carcinoma

Jens Bedke,Axel S Merseburger,Yohann Loriot,Daniel Castellano,Ernest Choy,Ignacio Duran,Jonathan E Rosenberg,Daniel P Petrylak,Robert Dreicer,Jose L Perez-Gracia,Jean H Hoffman-Censits,Michiel S Van Der Heijden

European urology focus, (2020)

WOSBibtex

Sequencing of PD-1/L1 Inhibitors and Carboplatin-Based Chemotherapy for Cisplatin-Ineligible Metastatic Urothelial Carcinoma

Xiao X Wei,Lillian Werner,Min Y Teo,Jonathan E Rosenberg,Vadim S Koshkin, Petros Grivas, Bernadett Szabados, Laura Morrison,Thomas Powles, Lucia Carril-Ajuria,Daniel Castellano, Pedro Isaacsson Velho

The Journal of urology, (2020)

WOSBibtex

View All

Base Info Papers Patents Projects